This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Grasselli G, Pesenti A, Cecconi M: Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA 2020; 323: 1545–1546.GrasselliGPesentiACecconiM:Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response.JAMA2020;323:1545–1546.10.1001/jama.2020.403132167538Search in Google Scholar
Fleming TR, Nason M, Krause PR, Longini IM, Henao-Restrepo AM: COVID-19 vaccine trials: the potential for „hybrid” analyses. Clin Trials 2021; 18: 391–397.FlemingTRNasonMKrausePRLonginiIMHenao-RestrepoAM:COVID-19 vaccine trials: the potential for „hybrid” analyses.Clin Trials2021;18:391–397.10.1177/17407745211018613831726834041932Search in Google Scholar
Gringeri M, Mosini G, Battini V, Cammarata G, Guarnieri G, Carnovale C et al.: Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility. Hum Vaccin Immunother 2021; 17: 2969–2971.GringeriMMosiniGBattiniVCammarataGGuarnieriGCarnovaleC:Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility.Hum Vaccin Immunother2021;17:2969–2971.10.1080/21645515.2021.1917236817100334043934Search in Google Scholar
Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M et al.: BNT162b2 vaccine induces neutralizing antibodies and polyspecific T cells in humans. Nature 2021; 595: 572–577.SahinUMuikAVoglerIDerhovanessianEKranzLMVormehrM:BNT162b2 vaccine induces neutralizing antibodies and polyspecific T cells in humans.Nature2021;595:572–577.10.1038/s41586-021-03653-634044428Search in Google Scholar
Skowronski DM, De Serres G: Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2021; 384: 1576–1577.SkowronskiDMDe SerresG:Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine.N Engl J Med2021;384:1576–1577.10.1056/NEJMc203624233596348Search in Google Scholar
Cohen D, Hazut Krauthammer S, Cohen YC, Perry C, Avivi I, Herishanu Y et al.: Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy. Eur J Nucl Med Mol Imaging 2021; 48: 3540–3549.CohenDHazut KrauthammerSCohenYCPerryCAviviIHerishanuY:Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.Eur J Nucl Med Mol Imaging2021;48:3540–3549.10.1007/s00259-021-05389-x810651233966088Search in Google Scholar
Cohen D, Krauthammer SH, Wolf I, Even-Sapir E: Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18 F]FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging 2021; 48: 1854–1863.CohenDKrauthammerSHWolfIEven-SapirE:Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18 F]FDG PET-CT and relevance to study interpretation.Eur J Nucl Med Mol Imaging2021;48:1854–1863.10.1007/s00259-021-05314-2800389433774684Search in Google Scholar
Eifer M, Tau N, Alhoubani Y, Kanana N, Domachevsky L, Shams J et al.: Covid-19 mRNA vaccination: age and immune status and its association with axillary lymph node PET/CT uptake. J Nucl Med 2021.EiferMTauNAlhoubaniYKananaNDomachevskyLShamsJ:Covid-19 mRNA vaccination: age and immune status and its association with axillary lymph node PET/CT uptake.J Nucl Med2021.10.2967/jnumed.121.262194871718233893188Search in Google Scholar
Hiller N, Goldberg SN, Cohen-Cymberknoh M, Vainstein V, Simanovsky N: Lymphadenopathy associated with the COVID-19 vaccine. Cureus 2021; 13: e13524.HillerNGoldbergSNCohen-CymberknohMVainsteinVSimanovskyN:Lymphadenopathy associated with the COVID-19 vaccine.Cureus2021;13:13524.10.7759/cureus.13524799436833786231Search in Google Scholar
Keshavarz P, Yazdanpanah F, Rafiee F, Mizandari M: Lymphadenopathy following COVID-19 vaccination: imaging findings review. Acad Radiol 2021; 28: 058–1071.KeshavarzPYazdanpanahFRafieeFMizandariM:Lymphadenopathy following COVID-19 vaccination: imaging findings review.Acad Radiol2021;28:058–1071.10.1016/j.acra.2021.04.007808821833985872Search in Google Scholar
Tu W, Gierada DS, Joe BN: COVID-19 vaccination-related lymphadenopathy: what to be aware if. Radiol Imaging Cancer 2021; 3: e210038.TuWGieradaDSJoeBN:COVID-19 vaccination-related lymphadenopathy: what to be aware if.Radiol Imaging Cancer2021;3:e210038.10.1148/rycan.2021210038804917133874733Search in Google Scholar
Vourtsis A, Berg WA: Breast density implications and supplemental screening. Eur Radiol 2019; 29: 1762–1777.VourtsisABergWA:Breast density implications and supplemental screening.Eur Radiol2019;29:1762–1777.10.1007/s00330-018-5668-8642086130255244Search in Google Scholar
Tagliafico AS, Mariscotti G, Valdora F, Durando M, Nori J, La Forgia D et al.: A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2). Eur J Cancer 2018; 104: 39–46.TagliaficoASMariscottiGValdoraFDurandoMNoriJLaForgia D:A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2).Eur J Cancer2018;104:39–46.10.1016/j.ejca.2018.08.02930316869Search in Google Scholar
Tagliafico AS, Valdora F, Mariscotti G, Durando M, Nori J, La Forgia D et al.: An exploratory radiomics analysis on digital breast tomosynthesis in women with mammographically negative dense breasts. Breast 2018; 40: 92–96.TagliaficoASValdoraFMariscottiGDurandoMNoriJLaForgia D:An exploratory radiomics analysis on digital breast tomosynthesis in women with mammographically negative dense breasts.Breast2018;40:92–96.10.1016/j.breast.2018.04.01629723697Search in Google Scholar
Dialani V, James DF, Slanetz PJ: A practical approach to imaging the axilla. Insights Imaging 2015; 6: 217–229.DialaniVJamesDFSlanetzPJ:A practical approach to imaging the axilla.Insights Imaging2015;6:217–229.10.1007/s13244-014-0367-8437681825534139Search in Google Scholar
Maxwell F, de Margerie Mellon C, Bricout M, Cauderlier E, Chapelier M, Albiter M et al.: Diagnostic strategy for the assessment of axillary lymph node status in breast cancer. Diagn Interv Imaging 2015; 96: 1089–1101.MaxwellFde Margerie MellonCBricoutMCauderlierEChapelierMAlbiterM:Diagnostic strategy for the assessment of axillary lymph node status in breast cancer.Diagn Interv Imaging2015;96:1089–1101.10.1016/j.diii.2015.07.00726372221Search in Google Scholar
Patel T, Given-Wilson RM, Thomas V: The clinical importance of axillary lymphadenopathy detected on screening mammography: revisited. Clinical radiology. 2005; 60: 64–71.PatelTGiven-WilsonRMThomasV:The clinical importance of axillary lymphadenopathy detected on screening mammography: revisited.Clinical radiology.2005;60:64–71.10.1016/j.crad.2004.05.00715642295Search in Google Scholar
Özütemiz C, Krystosek LA, Church AL, Chauhan A, Ellermann JM, Domingo-Musibay E et al.: Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncology patients. Radiology 2021; 300: E296–E300.ÖzütemizCKrystosekLAChurchALChauhanAEllermannJMDomingo-MusibayE:Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncology patients.Radiology2021;300:296–300.10.1148/radiol.2021210275790907233625300Search in Google Scholar
Becker AS, Perez-Johnston R, Chikarmane SA, Chen MM, El Homsi M, Feigin KN et al.: Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: Radiology Scientific Expert Panel. Radiology 2021; 300: E323–E327.BeckerASPerez-JohnstonRChikarmaneSAChenMMEl HomsiMFeiginKN:Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: Radiology Scientific Expert Panel.Radiology2021;300:323–327.10.1148/radiol.2021210436790907133625298Search in Google Scholar